Skip to main content

The CEO of Merck on Race, Leadership, and High Drug Prices

By February 26, 2018News
merck-logo

merck-logo

Kenneth Frazier, the CEO of the pharmaceutical company known as MSD outside of North America, discusses his upbringing and how it influences his leadership as chief executive. He is one of the few African-American CEOs in the Fortune 500, and shot to prominence after resigning from a council advising the Trump White House. Frazier discusses the importance of values in leadership and how Merck thinks about R&D and drug prices.

{iframe}https://hbr.org/ideacast/2018/02/the-ceo-of-merck-on-race-leadership-and-high-drug-prices?utm_medium=email&utm_source=newsletter_daily&utm_campaign=dailyalert&referral=00563&spMailingID=19036525&spUserID=MTM4NDQ0NTA1NTkS1&spJobID=1201093156&spReportId=MTIwMTA5MzE1NgS2{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.